Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $749.94 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $172.87 | 13 | $0 (2020) |
| Bausch & Lomb Americas Inc. | $110.03 | 1 | $0 (2022) |
| Allergan, Inc. | $82.42 | 5 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $66.24 | 4 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $55.81 | 4 | $0 (2017) |
| Abbott Laboratories | $40.52 | 2 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $30.23 | 2 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.35 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $23.12 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $21.98 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $110.03 | 1 | Bausch & Lomb Americas Inc. ($110.03) |
| 2021 | $23.42 | 1 | Abbott Laboratories ($23.42) |
| 2020 | $64.60 | 4 | Allergan, Inc. ($29.44) |
| 2019 | $157.43 | 11 | Janssen Pharmaceuticals, Inc ($59.87) |
| 2018 | $185.49 | 13 | Janssen Pharmaceuticals, Inc ($86.15) |
| 2017 | $208.97 | 14 | Otsuka America Pharmaceutical, Inc. ($55.81) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/14/2022 | Bausch & Lomb Americas Inc. | VISUDYNE (Drug) | Food and Beverage | In-kind items and services | $110.03 | General |
| Category: Ophthalmology | ||||||
| 10/21/2021 | Abbott Laboratories | CentriMag (Device) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Heart Failure | ||||||
| 04/25/2020 | Allergan, Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/04/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/27/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/08/2020 | Allergan, Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/13/2019 | iRhythm Technologies, Inc. | ZIO Patch (Device) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2019 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $17.10 | General |
| 09/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/14/2019 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 07/25/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/25/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/11/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/09/2019 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $11.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/28/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/10/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.94 | General |
| Category: Cardiovascular | ||||||
| 09/12/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/09/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/08/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 547 | 898 | $194,621 | $69,420 |
| 2022 | 10 | 505 | 845 | $174,791 | $57,570 |
| 2021 | 8 | 559 | 1,008 | $179,244 | $70,849 |
| 2020 | 9 | 536 | 860 | $151,428 | $63,244 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 152 | 433 | $68,587 | $25,856 | 37.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 123 | 193 | $43,772 | $17,110 | 39.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 108 | 108 | $46,138 | $13,583 | 29.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 76 | 76 | $17,328 | $6,359 | 36.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 36 | $10,454 | $3,309 | 31.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 52 | 52 | $8,341 | $3,204 | 38.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 152 | 420 | $66,528 | $21,382 | 32.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 74 | 76 | $32,467 | $10,945 | 33.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 80 | 127 | $28,804 | $9,337 | 32.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 40 | 43 | $9,804 | $3,358 | 34.3% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $8,294 | $3,065 | 36.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 58 | 59 | $9,204 | $3,053 | 33.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 33 | 33 | $9,583 | $2,663 | 27.8% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 14 | 33 | $3,881 | $1,664 | 42.9% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $4,182 | $1,413 | 33.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 13 | 13 | $2,044 | $690.25 | 33.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 181 | 506 | $66,792 | $26,301 | 39.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 96 | 217 | $41,013 | $16,030 | 39.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 104 | 106 | $37,736 | $14,782 | 39.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 79 | 80 | $10,400 | $4,267 | 41.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 37 | 37 | $8,954 | $3,584 | 40.0% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 23 | 23 | $6,624 | $2,523 | 38.1% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 21 | 21 | $4,305 | $1,941 | 45.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 18 | 18 | $3,420 | $1,420 | 41.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 178 | 440 | $58,080 | $24,264 | 41.8% |
About Dr. Brad Smith, MD
Dr. Brad Smith, MD is a Internal Medicine healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912916479.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brad Smith, MD has received a total of $749.94 in payments from pharmaceutical and medical device companies, with $110.03 received in 2022. These payments were reported across 44 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($749.94).
As a Medicare-enrolled provider, Smith has provided services to 2,147 Medicare beneficiaries, totaling 3,611 services with total Medicare billing of $261,082. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Springfield, MO
- Active Since 08/05/2006
- Last Updated 01/21/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1912916479
Products in Payments
- XARELTO (Drug) $172.87
- VISUDYNE (Drug) $110.03
- TEFLARO (Drug) $82.42
- ENTRESTO (Drug) $66.24
- SAMSCA (Drug) $55.81
- BROVANA (Drug) $30.23
- CentriMag (Device) $23.42
- RELISTOR (Drug) $23.35
- ELIQUIS (Drug) $21.98
- Lexiscan (Drug) $21.56
- JARDIANCE (Drug) $21.43
- NUCALA (Biological) $17.81
- PREVNAR - 13 (Biological) $13.86
- ZIO Patch (Device) $12.74
- Reveal LINQ (Device) $12.62
- JANUVIA (Drug) $12.09
- BRILINTA (Drug) $12.00
- CLEVIPREX (Drug) $11.26
- LOKELMA (Drug) $11.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Springfield
Dr. Steven Gradney, M.d, M.D
Internal Medicine — Payments: $568,658
Dr. James Bonucchi, Do, DO
Internal Medicine — Payments: $304,681
John Flack, Md, Mph, MD, MPH
Internal Medicine — Payments: $125,897
Dr. Sudeshna Banerjee, Md, MD
Internal Medicine — Payments: $62,767
Dr. Paul Madaj, M.d, M.D
Internal Medicine — Payments: $58,030
Dr. Indrajeet Mahata, M.d, M.D
Internal Medicine — Payments: $47,372